Datamatics Global Sets Ambitious Growth Targets: 13-15% Revenue CAGR and 20%+ PAT Growth

1 min read     Updated on 30 Oct 2025, 09:02 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Datamatics Global Services Limited aims for 13-15% revenue CAGR and over 20% PAT growth. The company plans to achieve this through AI-automation suites TruBot and TruAI, focusing on new enterprise deals in banking, financial services, insurance, and manufacturing sectors. With a strong cash position of ₹509.00 crores, Datamatics intends to support inorganic growth initiatives. Q2FY26 results show progress with revenue at ₹490.20 crore (20.50% YoY growth) and EBITDA at ₹88.80 crore (82.20% YoY growth). The company operates in three segments: Digital Operations, Digital Experiences, and Digital Technologies, all showing strong growth.

23383959

*this image is generated using AI for illustrative purposes only.

Datamatics Global Services Limited has announced ambitious growth targets, aiming for a 13-15% revenue compound annual growth rate (CAGR) with profit after tax (PAT) growth exceeding 20%. The company plans to achieve these targets through strategic initiatives and leveraging its AI-automation suites.

Key Growth Drivers

Datamatics is banking on its AI-automation suites, TruBot and TruAI, to drive growth. The company is also focusing on securing new enterprise deals in key sectors:

  • Banking
  • Financial Services
  • Insurance
  • Manufacturing

Financial Targets

Metric Target
Revenue CAGR 13-15%
PAT Growth >20%
EBITDA Margins >15%

Cash Position and Growth Initiatives

Datamatics maintains a strong cash position of ₹509.00 crores, which it plans to use to support inorganic growth initiatives through FY27. This substantial cash reserve provides the company with flexibility for potential acquisitions and investments in emerging technologies.

Q2FY26 Financial Highlights

The company's recent financial results for Q2FY26 demonstrate progress towards these ambitious targets:

Metric Q2FY26 YoY Growth
Revenue ₹490.20 crore 20.50%
EBITDA ₹88.80 crore 82.20%
EBITDA Margin 18.10% 613 bps
PAT ₹63.20 crore 49.30%

Segment Performance

Datamatics operates in three main segments:

  1. Digital Operations: Revenue of ₹272.48 crore with an EBIT margin of 16.70%
  2. Digital Experiences: Revenue of ₹64.62 crore with an EBIT margin of 10.80%
  3. Digital Technologies: Revenue of ₹153.13 crore with an EBIT margin of 10.80%

The company's focus on AI-powered products and services appears to be yielding results, with strong growth across all segments.

Management Commentary

Rahul Kanodia, Vice Chairman and CEO, stated, "We have continued our growth momentum from the previous quarter to Q2FY26, reporting a consolidated revenue of ₹490.20 crore, an increase of 4.80% QoQ. EBITDA stood at ₹88.80 crore, reflecting a substantial growth of 17% QoQ with EBITDA margin at 18.10%, driven by improved operational efficiencies and continued cost-optimization efforts."

Datamatics' ambitious growth targets and strong financial performance indicate the company's confidence in its AI-driven strategy and market positioning. As the company continues to leverage its technological capabilities and expand its presence in key sectors, investors and industry observers will be closely watching its progress towards these goals.

Historical Stock Returns for Datamatics Global Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-0.24%-4.85%-24.38%+19.96%+516.50%
Datamatics Global Services
View Company Insights
View All News
like15
dislike

Datamatics Partners with Well Pharmacy to Revolutionize Medication Record Management

1 min read     Updated on 14 Oct 2025, 12:11 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Datamatics Global Services Limited has partnered with Well Pharmacy, the UK's largest independent pharmacy chain, to modernize medication record-keeping for care home patients. The long-term contract involves implementing Datamatics' AI-powered automation platforms, TruCap+ and TruBot, to automate the Medication Administration Record (MAR) process. This initiative aims to enhance accuracy, improve efficiency, reduce costs, and increase productivity in managing patient records. Well Pharmacy plans to scale this solution to support over 70,000 patients in care homes, significantly impacting the UK's healthcare landscape.

21969663

*this image is generated using AI for illustrative purposes only.

Datamatics Global Services Limited , a leader in digital technologies, has announced a significant partnership with Well Pharmacy, the UK's largest independent pharmacy chain. This collaboration aims to modernize medication record-keeping for patients in care homes, leveraging Datamatics' AI-powered automation platforms.

Partnership Details

Well Pharmacy, operating over 650 pharmacies across the UK with an annual revenue of approximately £800 million, has signed a long-term contract with Datamatics. The partnership will focus on automating the Medication Administration Record (MAR) process, utilizing Datamatics' intelligent automation products:

  • TruCap+: For Intelligent Document Processing (IDP)
  • TruBot: For Robotic Process Automation (RPA)

Automation Benefits

The implementation of these AI-powered platforms is expected to bring several advantages:

Benefit Description
Enhanced Accuracy Minimizes manual errors in patient records
Improved Efficiency Automates updates and reduces manual effort
Cost Reduction Lowers manual effort and reduces wastage
Scalability Manages varied prescription formats at high volumes
Increased Productivity Allows pharmacists and care teams to focus more on patient care

Scope and Impact

The automation initiative aims to create reliable Monitored Dosage System (MDS) records while enhancing patient safety. Well Pharmacy plans to scale this solution to support over 70,000 patients in care homes, significantly impacting the UK's healthcare landscape.

Strategic Importance

This partnership reinforces Datamatics' position in the global healthcare sector. Notably, Datamatics' Intelligent Automation platform is already empaneled by NHS Shared Business Services in the UK, highlighting its growing influence in the healthcare industry.

Andrew Caplan, Chief Retail Officer from Well Pharmacy, emphasized the critical nature of accuracy in the medical industry and how this partnership provides a flexible, easy-to-use solution ensuring precision while simplifying complex processes.

Mitul Mehta, Chief Marketing Officer at Datamatics, expressed excitement about the partnership, stating, "With our experience in the Healthcare industry, we are confident to deliver the desired benefits of automation including accuracy, efficiency and process compliance."

This collaboration between Datamatics and Well Pharmacy represents a significant step forward in the digital transformation of healthcare services, promising to enhance patient care through innovative technology solutions.

Historical Stock Returns for Datamatics Global Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-0.24%-4.85%-24.38%+19.96%+516.50%
Datamatics Global Services
View Company Insights
View All News
like16
dislike

More News on Datamatics Global Services

1 Year Returns:+19.96%